Correlation Between Keros Therapeutics and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Nuvalent, you can compare the effects of market volatilities on Keros Therapeutics and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Nuvalent.
Diversification Opportunities for Keros Therapeutics and Nuvalent
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Keros and Nuvalent is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Nuvalent go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Nuvalent
Given the investment horizon of 90 days Keros Therapeutics is expected to under-perform the Nuvalent. In addition to that, Keros Therapeutics is 4.79 times more volatile than Nuvalent. It trades about -0.18 of its total potential returns per unit of risk. Nuvalent is currently generating about -0.13 per unit of volatility. If you would invest 9,562 in Nuvalent on October 26, 2024 and sell it today you would lose (1,298) from holding Nuvalent or give up 13.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Keros Therapeutics vs. Nuvalent
Performance |
| Timeline |
| Keros Therapeutics |
| Nuvalent |
Keros Therapeutics and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Keros Therapeutics and Nuvalent
The main advantage of trading using opposite Keros Therapeutics and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |